| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥242.4B | ¥246.9B | -1.8% |
| Operating Income | ¥4.4B | ¥6.7B | -34.0% |
| Ordinary Income | ¥3.3B | ¥8.2B | -60.2% |
| Net Income | ¥3.6B | ¥7.2B | -49.5% |
| ROE | 1.8% | 3.8% | - |
FY2026 Q3 results show revenue of 242.4 billion yen (YoY -1.8%), operating income of 4.4 billion yen (YoY -34.0%), ordinary income of 3.3 billion yen (YoY -60.2%), and net income of 3.6 billion yen (YoY -49.5%). The company experienced significant profit deterioration despite relatively stable revenue. Operating margin compressed to 1.8% from 2.7% in the prior year, reflecting a 16.6% gross profit margin and elevated SG&A expenses of 35.8 billion yen representing 14.8% of revenue. The substantial gap between operating income and ordinary income reflects net non-operating expenses of 1.1 billion yen. However, comprehensive income reached 15.0 billion yen, substantially exceeding net income due to unrealized gains on investment securities of 10.8 billion yen. Basic EPS declined 51.6% to 8.87 yen. The company maintains full-year guidance of 340.0 billion yen revenue (YoY +4.0%) and 9.0 billion yen operating income (YoY +8.6%), requiring significant improvement in the remaining period.
Revenue declined 1.8% to 242.4 billion yen, reflecting modest top-line pressure. Cost of sales of 202.1 billion yen resulted in gross profit of 40.3 billion yen at a 16.6% margin, indicating limited pricing power or product mix challenges. SG&A expenses remained elevated at 35.8 billion yen (14.8% of revenue), compressing operating profit to 4.4 billion yen and generating a thin 1.8% operating margin. The operating profit decline of 34.0% substantially outpaced the modest revenue decline, indicating negative operating leverage.
Non-operating items created a net expense of 1.1 billion yen. Non-operating income of 2.2 billion yen included dividend income of 1.7 billion yen and minor FX gains of 0.1 billion yen. Non-operating expenses totaled 3.4 billion yen, comprising interest expense of 0.5 billion yen, FX losses of 0.2 billion yen, and other expenses of 1.6 billion yen. Equity method income contributed 1.2 billion yen. The net non-operating burden reduced operating income to ordinary income of 3.3 billion yen, a 60.2% YoY decline.
Extraordinary items provided net support of 0.9 billion yen, with gains on sale of securities of 1.1 billion yen partially offset by extraordinary losses of 0.2 billion yen. These non-recurring items helped lift profit before tax to 4.2 billion yen. After tax expenses of 0.6 billion yen and non-controlling interest deduction of 0.3 billion yen, net income attributable to owners reached 3.6 billion yen, down 49.5%.
The gap between ordinary income (3.3 billion yen) and net income (3.6 billion yen) of approximately 9% is attributable to extraordinary gains on securities sales. This gap highlights the role of non-recurring items in supporting bottom-line results. Comprehensive income of 15.0 billion yen significantly exceeded net income due to other comprehensive income items, primarily unrealized gains on available-for-sale securities of 10.8 billion yen, FX translation adjustments of 0.3 billion yen, and share of OCI from equity method investments of 0.3 billion yen.
This represents a revenue down/profit down pattern, with profit declining at a substantially faster rate than revenue due to margin compression and elevated operating expenses, partially offset by non-recurring gains from investment securities.
[Profitability] ROE of 1.8% reflects significant deterioration in profitability, substantially below typical manufacturing sector standards. Operating margin of 1.8% (down from 2.7% YoY) and net profit margin of 1.5% indicate severe profitability challenges. Gross profit margin of 16.6% suggests limited pricing power or unfavorable product mix. The company generated EBIT of approximately 4.4 billion yen on revenue of 242.4 billion yen. DuPont analysis reveals the low ROE stems primarily from thin net profit margin of 1.4%, combined with asset turnover of 0.59 times and financial leverage of 2.0 times. [Cash Quality] Cash and deposits increased substantially to 55.5 billion yen from 29.4 billion yen YoY, providing strong liquidity coverage. Short-term debt coverage ratio stands at approximately 16.3 times (cash to short-term borrowings). However, working capital efficiency shows room for improvement with trade receivables at 80.2 billion yen and inventories at 30.5 billion yen. Operating working capital turnover of approximately 164 days indicates extended cash conversion cycles. [Investment Efficiency] Total asset turnover of 0.59 times is below the industry median of 0.56 times but indicates slow asset utilization. ROIC of approximately 1.8% reflects weak returns on deployed capital. Investment securities represent a substantial 106.6 billion yen (25.9% of total assets), indicating significant capital allocation to financial investments rather than operating assets. [Financial Health] Equity ratio of 49.9% (205.5 billion yen equity against 411.6 billion yen total assets) provides moderate financial stability. Current ratio of 205.0% and quick ratio of 174.8% demonstrate strong short-term liquidity. Debt-to-equity ratio of approximately 0.28 (interest-bearing debt of 57.8 billion yen) reflects conservative leverage. Long-term loans of 54.4 billion yen represent the primary debt obligation. Net defined benefit liability of 16.6 billion yen represents a material post-employment obligation. Interest coverage of approximately 9.2 times (EBIT to interest expense) indicates adequate debt service capacity despite low profitability.
Cash and deposits increased 88.7% or 26.1 billion yen YoY to reach 55.5 billion yen, representing a substantial liquidity improvement. This increase occurred despite declining operating profitability, suggesting cash generation from non-operating activities or balance sheet optimization. Trade receivables increased to 80.2 billion yen, while inventories stood at 30.5 billion yen including finished goods of 30.5 billion yen, work in process of 14.5 billion yen, and raw materials of 10.7 billion yen. Trade payables of 60.5 billion yen represent effective utilization of supplier credit. The substantial increase in investment securities to 106.6 billion yen combined with realized gains on securities sales of 1.1 billion yen suggests portfolio repositioning activity. Working capital metrics indicate extended cycles with receivables turnover of approximately 121 days and inventory turnover of approximately 101 days, creating cash conversion challenges. The 0.7 billion yen increase in short-term borrowings to 3.4 billion yen represents modest debt utilization. Property, plant and equipment of 90.7 billion yen suggests ongoing capital intensity in operations. The cash buildup combined with realized securities gains indicates possible asset monetization or financing activity supporting liquidity. Coverage of short-term liabilities (101.3 billion yen) by cash stands at 0.55 times, while the broader current ratio of 2.05 times provides comfortable liquidity buffers. The substantial unrealized gains on securities of 10.8 billion yen in comprehensive income suggest appreciation of the investment portfolio contributed to equity position improvement.
Operating income of 4.4 billion yen declined to ordinary income of 3.3 billion yen, reflecting net non-operating expenses of approximately 1.1 billion yen or 0.5% of revenue. Non-operating income totaled 2.2 billion yen, primarily comprising dividend income of 1.7 billion yen from the substantial investment securities portfolio and minor FX gains of 0.1 billion yen. Non-operating expenses of 3.4 billion yen included interest expense of 0.5 billion yen, FX losses of 0.2 billion yen, and other non-operating expenses of 1.6 billion yen. The non-operating net burden indicates that financial investments, while providing dividend income, also generate volatility through FX exposures and other non-operating costs. Extraordinary gains on securities sales of 1.1 billion yen represent non-recurring items that lifted net income above ordinary income, comprising approximately 30% of reported net income. This dependency on non-recurring gains raises concerns about earnings sustainability. Equity method income of 1.2 billion yen from associated companies provides additional support. The substantial divergence between net income of 3.6 billion yen and comprehensive income of 15.0 billion yen reflects 10.8 billion yen in unrealized gains on available-for-sale securities, representing mark-to-market appreciation rather than realized operating performance. While cash and deposits increased substantially, the weak operating margin and extended working capital cycles suggest operating cash generation may be under pressure. The combination of thin operating margins, dependency on securities-related gains, and large unrealized valuation gains in comprehensive income indicates earnings quality warrants careful monitoring, with focus needed on core operating performance improvement rather than financial asset management.
Full-year guidance calls for revenue of 340.0 billion yen (YoY +4.0%), operating income of 9.0 billion yen (YoY +8.6%), and ordinary income of 7.5 billion yen (YoY -37.3%). Q3 cumulative revenue of 242.4 billion yen represents 71.3% progress toward the 340.0 billion yen full-year target, slightly below the standard 75% benchmark for Q3. Operating income of 4.4 billion yen represents 48.9% of the 9.0 billion yen target, significantly below the 75% standard and indicating substantial improvement is required in Q4. The guidance implies Q4 operating income of approximately 4.6 billion yen, which would exceed the entire Q3 YTD performance. This aggressive fourth-quarter assumption suggests either seasonal factors, expected business recovery, or planned cost reduction initiatives. The forecasted operating margin would improve to approximately 2.6% for the full year (9.0 billion yen on 340.0 billion yen), representing improvement from the 1.8% Q3 margin. EPS guidance of 14.75 yen implies full-year net income of approximately 5.5 billion yen based on 37,283 thousand average shares. Annual dividend forecast remains at 4.00 yen with no revision announced this quarter. The company noted that forward-looking statements are based on currently available information and certain reasonable assumptions, with actual results potentially differing materially due to various factors. No forecast revision was made this quarter despite the significant shortfall in profit progress rates, suggesting management maintains confidence in fourth-quarter recovery scenarios or has limited visibility to justify revision at this point.
Annual dividend forecast is 4.00 yen per share, unchanged from prior guidance. Based on forecasted EPS of 14.75 yen, the payout ratio would be approximately 27.1%. However, based on actual Q3 cumulative EPS of 8.87 yen and assuming the 4.00 yen dividend applies to the full year, the payout ratio against current earnings run-rate would be approximately 45.1%. The company paid no interim dividend in Q2, indicating a year-end lump-sum dividend policy. With net income of 3.6 billion yen for the nine-month period and 37,283 thousand average shares outstanding, the annualized dividend of 4.00 yen per share would represent approximately 1.5 billion yen in total dividends (4.00 yen times 37,287 thousand shares outstanding). This represents a payout ratio of approximately 27% against full-year forecasted net income of 5.5 billion yen. Cash and deposits of 55.5 billion yen provide ample coverage for the estimated 1.5 billion yen dividend commitment, with cash covering dividends approximately 37 times. No share buyback program was disclosed. The dividend policy appears sustainable from a cash perspective given the strong cash position, though the sustainability depends on achievement of full-year earnings guidance. The absence of dividend revision despite significant profit shortfall suggests management confidence in maintaining shareholder returns, though the payout ratio would rise materially if full-year earnings fall short of guidance.
Profitability pressure from persistent low gross margins of 16.6% combined with elevated SG&A expenses represent the primary operational risk, as operating margin of 1.8% leaves minimal buffer for volume decline or cost increases. The company's thin margins are vulnerable to raw material cost inflation, competitive pricing pressure, or unfavorable product mix shifts. Operating leverage is negative as demonstrated by revenue declining 1.8% while operating profit declined 34.0%.
Working capital inefficiency with receivables turnover of 121 days and inventory turnover of 101 days creates cash conversion risk and ties up significant capital. Trade receivables of 80.2 billion yen and inventories of 30.5 billion yen represent 33.1% and 12.6% of revenue respectively. Extended collection periods increase credit risk exposure, while high inventory levels risk obsolescence or write-downs, particularly if demand weakens. The operating working capital cycle of approximately 164 days substantially exceeds efficient benchmarks.
Investment securities concentration risk with 106.6 billion yen (25.9% of total assets) allocated to financial investments creates substantial exposure to market volatility. While unrealized gains of 10.8 billion yen boosted comprehensive income in the current period, these gains are volatile and could reverse, impacting equity and comprehensive income. The company's dependency on dividend income of 1.7 billion yen and realized securities gains of 1.1 billion yen to support overall profitability indicates vulnerability to equity market corrections or dividend cuts by portfolio companies. This concentration diverts capital from core operating activities and creates volatility in reported comprehensive income.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics indicate significant underperformance relative to manufacturing sector medians. ROE of 1.8% substantially trails the industry median of 5.8% (IQR: 3.1%-8.4%), placing the company in the bottom quartile. Operating margin of 1.8% is significantly below the industry median of 8.9% (IQR: 5.4%-12.7%), reflecting structural profitability challenges. Net profit margin of 1.5% compares unfavorably to the industry median of 6.5% (IQR: 3.3%-9.4%). ROA of 0.9% (calculated as net income to total assets) is substantially below the industry median of 3.4% (IQR: 1.8%-5.2%). ROIC of approximately 1.8% trails the industry median of 6.0% (IQR: 3.0%-10.0%).
Financial health metrics show relative strength. Equity ratio of 49.9% is below the industry median of 63.8% (IQR: 49.1%-74.8%), placing the company near the lower quartile but within acceptable ranges. Current ratio of 2.05 times is below the industry median of 2.87 times (IQR: 2.13x-3.84x), though still indicating adequate liquidity. Financial leverage of 2.0 times exceeds the industry median of 1.53 times (IQR: 1.31-1.86), reflecting above-average use of debt financing relative to equity.
Efficiency metrics reveal mixed positioning. Asset turnover of 0.59 times slightly exceeds the industry median of 0.56 times (IQR: 0.41-0.65), suggesting comparable asset utilization. However, working capital metrics show inefficiency with receivables turnover of approximately 121 days substantially exceeding the industry median of 85.4 days (IQR: 68.8-116.9 days) and inventory turnover of approximately 101 days below the industry median of 112.3 days (IQR: 50.3-163.3 days). Payables turnover appears within normal ranges. Operating working capital turnover of approximately 164 days exceeds the industry median of 111.5 days (IQR: 72.4-144.1 days), indicating below-average cash conversion efficiency.
Growth metrics show underperformance. Revenue decline of 1.8% compares unfavorably to industry median growth of 2.8% (IQR: -1.5% to +8.8%). EPS decline of 51.6% significantly underperforms the industry median EPS growth of 9% (IQR: -20% to +33%).
The company's positioning reflects structural profitability challenges with operating margins approximately one-fifth of industry medians, while maintaining adequate but below-median financial stability metrics. The substantial allocation to investment securities (25.9% of assets) represents an atypical capital structure for a manufacturing company.
(※ Industry: Manufacturing sector, N=105 companies for most metrics, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Key Takeaways from Q3 Earnings: First, the company faces severe core business profitability challenges, with operating margin of 1.8% representing less than one-fifth of industry median levels and indicating fundamental competitive or structural issues requiring operational restructuring. The 34% operating income decline on only 1.8% revenue decline demonstrates negative operating leverage and suggests fixed cost structures are misaligned with current revenue levels. Second, reported earnings quality is heavily dependent on non-recurring items and unrealized investment gains, with securities sales gains of 1.1 billion yen representing 30% of net income and unrealized securities appreciation of 10.8 billion yen comprising 72% of comprehensive income, raising sustainability concerns about reported profitability absent core business improvement. Third, significant working capital inefficiency with 121-day receivables turnover and 164-day working capital cycle indicates operational execution challenges and represents a substantial opportunity for cash generation if receivables collection and inventory management improve to industry median levels, potentially freeing up approximately 30-40 billion yen in working capital based on revenue base. The substantial cash build to 55.5 billion yen alongside declining operating profitability suggests possible asset monetization or non-operating sources supporting liquidity while core operations struggle. Fourth, achievement of full-year guidance requires Q4 operating income of approximately 4.6 billion yen, exceeding total Q3 YTD performance, which implies either material seasonal weighting, significant business recovery, or aggressive cost reduction initiatives must materialize in the final quarter; the 48.9% progress rate on operating income versus 71.3% on revenue at Q3 creates execution risk for guidance attainment.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.